Literature DB >> 15010830

Alphavirus vectors for cancer gene therapy (review).

Ryuya Yamanaka1.   

Abstract

Alphaviruses have several characteristics that make them attractive as gene therapy vectors such as transient and high-level expression of a heterologous gene. Alphavirus vectors, Semliki Forest virus (SFV), Sindbis virus (SIN) and Venezuelan equine encephalitis virus (VEE) have been developed as gene expression vectors. Alphaviruses are positive-strand RNA viruses that can mediate efficient cytoplasmic gene expression in mammalian cells. The alphavirus RNA replication machinery has been engineered for high level heterologous gene expression. Since an RNA virus vector cannot integrate into chromosomal DNA, concerns about cell transformation are reduced. Alphavirus vectors demonstrate promise for the safe tumor-killing and tumor-specific immune responses. Recombinant alphavirus RNA replicons may facilitate gene therapy of cancer.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15010830

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  6 in total

1.  Sindbis virus with a tricomponent genome.

Authors:  Rafik Fayzulin; Rodion Gorchakov; Olga Petrakova; Evgenia Volkova; Ilya Frolov
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

2.  Initial testing of the replication competent Seneca Valley virus (NTX-010) by the pediatric preclinical testing program.

Authors:  Christopher L Morton; Peter J Houghton; E Anders Kolb; Richard Gorlick; C Patrick Reynolds; Min H Kang; John M Maris; Stephen T Keir; Jianrong Wu; Malcolm A Smith
Journal:  Pediatr Blood Cancer       Date:  2010-08       Impact factor: 3.167

3.  Semliki forest virus expressing interleukin-12 induces antiviral and antitumoral responses in woodchucks with chronic viral hepatitis and hepatocellular carcinoma.

Authors:  Juan R Rodriguez-Madoz; Katherine H Liu; Jose I Quetglas; Marta Ruiz-Guillen; Itziar Otano; Julien Crettaz; Scott D Butler; Christine A Bellezza; Nathan L Dykes; Bud C Tennant; Jesus Prieto; Gloria González-Aseguinolaza; Cristian Smerdou; Stephan Menne
Journal:  J Virol       Date:  2009-09-09       Impact factor: 5.103

Review 4.  Long-term gene expression in dividing and nondividing cells using SV40-derived vectors.

Authors:  David S Strayer; Lokesh Agrawal; Pierre Cordelier; Bianling Liu; Jean-Pierre Louboutin; Elena Marusich; Hayley J McKee; Carmen N NiGongyi Ren; Marlene S Strayer
Journal:  Mol Biotechnol       Date:  2006-10       Impact factor: 2.860

5.  Prime-boost vaccination with plasmid and adenovirus gene vaccines control HER2/neu+ metastatic breast cancer in mice.

Authors:  Xiaoyan Wang; Jian-Ping Wang; Xiao-Mei Rao; Janet E Price; Heshan S Zhou; Lawrence B Lachman
Journal:  Breast Cancer Res       Date:  2005-05-23       Impact factor: 6.466

6.  Oncolytic activity of Sindbis virus in human oral squamous carcinoma cells.

Authors:  K Saito; K Uzawa; A Kasamatsu; K Shinozuka; K Sakuma; M Yamatoji; M Shiiba; Y Shino; H Shirasawa; H Tanzawa
Journal:  Br J Cancer       Date:  2009-07-28       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.